Terms: = Germ cell tumor AND OLIG2, OLIGO2, 10215, ENSG00000205927, BHLHB1, RACK17, PRKCBP2 AND Treatment
61 results:
1. Lucanthone, a Potential PPT1 Inhibitor, Perturbs Stemness, Reduces tumor Microtube Formation, and Slows the Growth of Temozolomide-Resistant Gliomas In Vivo.
Radin DP; Shifman S; Outhwaite IR; Sharma A; Bases R; Seeliger MA; Tsirka SE
J Pharmacol Exp Ther; 2024 Mar; 389(1):51-60. PubMed ID: 38296645
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic model for assessing the human glioma cell malignancy grade based on MDM2, MELK, SOX2, CDK4, DR5 and OCT4 gene expression.
Tyagunova EE; Drozd SF; Kalennik OV; Samoylenkova NS; Savchenko EA; Danilov GV; Pavlova GV
Zh Vopr Neirokhir Im N N Burdenko; 2023; 87(6):43-51. PubMed ID: 38054226
[TBL] [Abstract] [Full Text] [Related]
3. Deciphering the Action of Neuraminidase in Glioblastoma Models.
Baeza-Kallee N; Bergès R; Hein V; Cabaret S; Garcia J; Gros A; Tabouret E; Tchoghandjian A; Colin C; Figarella-Branger D
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511403
[TBL] [Abstract] [Full Text] [Related]
4. Oligodendrocyte Transcription Factor 2 as a Potential Prognostic Biomarker of Glioblastoma: Kaplan-Meier Analysis and the Development of a Binary Predictive Model Based on Visually Accessible Rembrandt Image and Magnetic Resonance Imaging Radiomic Features.
Mei N; Lu Y; Yang S; Jiang S; Ruan Z; Wang D; Liu X; Ying Y; Li X; Yin B
J Comput Assist Tomogr; 2023 Jul-Aug 01; 47(4):650-658. PubMed ID: 37380154
[TBL] [Abstract] [Full Text] [Related]
5. Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker.
Martínez-Bosch N; Vilariño N; Alameda F; Mojal S; Arumí-Uria M; Carrato C; Aldecoa I; Ribalta T; Vidal N; Bellosillo B; Menéndez S; Del Barco S; Gallego O; Pineda E; López-Martos R; Hernández A; Mesia C; Esteve-Codina A; de la Iglesia N; Balañá C; Martínez-García M; Navarro P
Cells; 2023 Mar; 12(6):. PubMed ID: 36980184
[TBL] [Abstract] [Full Text] [Related]
6. MN1 altered astroblastoma with APC and LRP1B gene mutations: a unique variant in the cervical spine of a pediatric patient.
Mugge L; Dang DD; Stabingas K; Keating G; Rossi C; Keating R
Childs Nerv Syst; 2023 May; 39(5):1309-1315. PubMed ID: 36648513
[TBL] [Abstract] [Full Text] [Related]
7. Olig1/2-Expressing Intermediate Lineage Progenitors Are Predisposed to PTEN/p53-Loss-Induced Gliomagenesis and Harbor Specific Therapeutic Vulnerabilities.
Verma R; Chen X; Xin D; Luo Z; Ogurek S; Xin M; Rao R; Berry K; Lu QR
Cancer Res; 2023 Mar; 83(6):890-905. PubMed ID: 36634201
[TBL] [Abstract] [Full Text] [Related]
8. Methionine regulates self-renewal, pluripotency, and cell death of GIC through cholesterol-rRNA axis.
Yokogami K; Kikuchi T; Watanabe T; Nakatake Y; Yamashita S; Mizuguchi A; Takeshima H
BMC Cancer; 2022 Dec; 22(1):1351. PubMed ID: 36564758
[TBL] [Abstract] [Full Text] [Related]
9. The spectrum of morphological findings in pediatric central nervous system MN1-fusion-positive neuroepithelial tumors.
Lubieniecki F; Vazquez V; Lamas GS; Camarero S; Nuñez FJ; Baroni L; Schüller U; Alderete D
Childs Nerv Syst; 2023 Feb; 39(2):379-386. PubMed ID: 36534132
[TBL] [Abstract] [Full Text] [Related]
10. Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.
Keck MK; Sill M; Wittmann A; Joshi P; Stichel D; Beck P; Okonechnikow K; Sievers P; Wefers AK; Roncaroli F; Avula S; McCabe MG; Hayden JT; Wesseling P; Øra I; Nistér M; Kranendonk MEG; Tops BBJ; Zapotocky M; Zamecnik J; Vasiljevic A; Fenouil T; Meyronet D; von Hoff K; Schüller U; Loiseau H; Figarella-Branger D; Kramm CM; Sturm D; Scheie D; Rauramaa T; Pesola J; Gojo J; Haberler C; Brandner S; Jacques T; Sexton Oates A; Saffery R; Koscielniak E; Baker SJ; Yip S; Snuderl M; Ud Din N; Samuel D; Schramm K; Blattner-Johnson M; Selt F; Ecker J; Milde T; von Deimling A; Korshunov A; Perry A; Pfister SM; Sahm F; Solomon DA; Jones DTW
Acta Neuropathol; 2023 Jan; 145(1):49-69. PubMed ID: 36437415
[TBL] [Abstract] [Full Text] [Related]
11. Recurrent high-grade astroblastoma with
Sun D; Liu J; Xiao L; Guan H
Clin Neuropathol; 2023; 42(1):30-39. PubMed ID: 36366964
[TBL] [Abstract] [Full Text] [Related]
12. Correlation of Clinicopathological Factors with Brain tumor-Related Epilepsy in Glioma.
Wang Z; Yang W; Wang Y; Aili Y; Wang Z; Wang Q; Jiang S; Zhang G; Zhang J; Li B
Dis Markers; 2022; 2022():4918294. PubMed ID: 36246555
[TBL] [Abstract] [Full Text] [Related]
13. [Diffuse midline gliomas with H3K27 alteration in children: a clinicopathological analysis of forty-one cases].
Li J; Ma YY; Feng J; Zhao D; Ding F; Tian L; Chen R; Zhao R
Zhonghua Bing Li Xue Za Zhi; 2022 Apr; 51(4):319-325. PubMed ID: 35359043
[No Abstract] [Full Text] [Related]
14. The Epigenetic Regulation of olig2 by Histone Demethylase KDM6B in Glioma cells.
Sui A; Han B; Ren W; He W; Gao C; Han X; Liu S; Zhang Y; Qi X; Guo X
J Mol Neurosci; 2022 May; 72(5):939-946. PubMed ID: 35132566
[TBL] [Abstract] [Full Text] [Related]
15. Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors.
Knudsen AM; Halle B; Cédile O; Burton M; Baun C; Thisgaard H; Anand A; Hubert C; Thomassen M; Michaelsen SR; Olsen BB; Dahlrot RH; Bjerkvig R; Lathia JD; Kristensen BW
Neuro Oncol; 2022 Jul; 24(7):1074-1087. PubMed ID: 34964899
[TBL] [Abstract] [Full Text] [Related]
16. Gene clusters based on olig2 and CD276 could distinguish molecular profiling in glioblastoma.
Fu M; Zhang J; Li W; He S; Zhang J; Tennant D; Hua W; Mao Y
J Transl Med; 2021 Sep; 19(1):404. PubMed ID: 34565408
[TBL] [Abstract] [Full Text] [Related]
17. Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP downregulates stemness phenotype and mesenchymal trans-differentiation after irradiation in glioblastoma multiforme.
Lee SH; Kwon HJ; Park S; Kim CI; Ryu H; Kim SS; Park JB; Kwon JT
PLoS One; 2021; 16(9):e0257375. PubMed ID: 34516577
[TBL] [Abstract] [Full Text] [Related]
18. Overview and recent advances in the targeting of medulloblastoma cancer stem cells.
Paul MR; Zage PE
Expert Rev Anticancer Ther; 2021 Sep; 21(9):957-974. PubMed ID: 34047251
[No Abstract] [Full Text] [Related]
19. Glioblastoma TCGA Mesenchymal and IGS 23 tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy.
Carrato C; Alameda F; Esteve-Codina A; Pineda E; Arpí O; Martinez-García M; Mallo M; Gut M; Lopez-Martos R; Barco SD; Ribalta T; Capellades J; Puig J; Gallego O; Mesia C; Muñoz-Marmol AM; Archilla I; Arumí M; Blanc JM; Bellosillo B; Menendez S; Esteve A; Bagué S; Hernandez A; Craven-Bartle J; Fuentes R; Vidal N; Aldecoa I; Iglesia N; Balana C
Clin Cancer Res; 2020 Dec; 26(24):6600-6609. PubMed ID: 32998960
[TBL] [Abstract] [Full Text] [Related]
20. Establishment of age group classification for risk stratification in glioma patients.
Lin Z; Yang R; Li K; Yi G; Li Z; Guo J; Zhang Z; Junxiang P; Liu Y; Qi S; Huang G
BMC Neurol; 2020 Aug; 20(1):310. PubMed ID: 32819307
[TBL] [Abstract] [Full Text] [Related]
[Next]
